Amryt Pharma (NASDAQ: AMYT)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Amryt Pharma (NASDAQ: AMYT) through any online brokerage.
The latest price target for Amryt Pharma (NASDAQ: AMYT) was reported by SVB Leerink on Friday, June 24, 2022. The analyst firm set a price target for 19.00 expecting AMYT to rise to within 12 months (a possible 163.89% upside). 8 analyst firms have reported ratings in the last year.
The stock price for Amryt Pharma (NASDAQ: AMYT) is $7.2 last updated June 24, 2022, 8:00 PM UTC.
There are no upcoming dividends for Amryt Pharma.
Amryt Pharma’s Q2 earnings are confirmed for Friday, August 5, 2022.
There is no upcoming split for Amryt Pharma.
Amryt Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.